These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30073970)

  • 1. Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study.
    Caruso C; Borgonovo L; Bramé B; Cocconcelli A; Colantuono S; Piantanida M; Scarpa S; Zisa G; Romano A
    J Investig Allergol Clin Immunol; 2018 Aug; 28(4):283-284. PubMed ID: 30073970
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
    Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
    Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy.
    Worm M; Higenbottam T; Pfaar O; Mösges R; Aberer W; Gunawardena K; Wessiepe D; Lee D; Kramer MF; Skinner M; Lees B; Zielen S
    Allergy; 2018 Sep; 73(9):1812-1822. PubMed ID: 29779247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy.
    Lund L; Henmar H; Würtzen PA; Lund G; Hjortskov N; Larsen JN
    Clin Exp Allergy; 2007 Apr; 37(4):564-71. PubMed ID: 17430354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K; van der Werf JF; Boot D; van Ree R
    Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent.
    Worm M; Ernst D; Kraller M; Babina M
    Int Arch Allergy Immunol; 2017; 172(1):20-26. PubMed ID: 28219062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative evaluation of the biological action of allergens and allergoids prepared from plant pollen by the double radial immunodiffusion method].
    Lavrenchik EI; Korytina OL
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):94-6. PubMed ID: 2480040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
    Pfaar O; van Twuijver E; Hecker H; Boot JD; van Ree R; Klimek L
    Int Arch Allergy Immunol; 2013; 160(4):420-4. PubMed ID: 23183541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergoids for Allergy Treatment.
    Carnes J; Gallego MT; Moya R; Iraola V
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):110-119. PubMed ID: 29473530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
    Tari MG; Mancino M; Ghezzi E; Frank E; Cromwell O
    Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy?
    Nakonechna A; Hills J; Moor J; Dore P; Abuzakouk M
    Ann Allergy Asthma Immunol; 2015 Jan; 114(1):73-4. PubMed ID: 25457868
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical investigation of the cellular infiltrates at the sites of allergoid-induced late-phase cutaneous reactions associated with pollen allergen-specific immunotherapy.
    Eberlein-König B; Jung C; Rakoski J; Ring J
    Clin Exp Allergy; 1999 Dec; 29(12):1641-7. PubMed ID: 10594540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties.
    Cirković T; Gavrović-Jankulović M; Prisić S; Jankov RM; Burazer L; Vucković O; Sporcić Z; Paranos S
    Allergy; 2002 Nov; 57(11):1013-20. PubMed ID: 12358997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial.
    Ariano R; Kroon AM; Augeri G; Canonica GW; Passalacqua G
    Allergy; 1999 Apr; 54(4):313-9. PubMed ID: 10371089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines.
    Sola J; Sánchez V; Landeta A; Madariaga B; Martínez A; Álvarez-Cuesta E
    Immunotherapy; 2015; 7(4):343-52. PubMed ID: 25917626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
    Asero R; Mistrello G; Amato S
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.